Shown: posts 1 to 3 of 3. This is the beginning of the thread.
Posted by JohnX on October 21, 2001, at 16:21:58
Why start with cytalopram in this
star-D program? I hope this
is this because of its lack of
interactions with other meds, and
not Forest Labs marketing/sales team
which throws extravagant parties for
psychiatrists (according both to my pdoc
and a close pharmacist friend).-john
Posted by Mitch on October 21, 2001, at 17:21:22
In reply to star-D and citalopram?, posted by JohnX on October 21, 2001, at 16:21:58
>
> Why start with cytalopram in this
> star-D program? I hope this
> is this because of its lack of
> interactions with other meds, and
> not Forest Labs marketing/sales team
> which throws extravagant parties for
> psychiatrists (according both to my pdoc
> and a close pharmacist friend).
>
> -johnJohn,
I think they might have chosen it because it has less affinity for the other receptors (NE/DA) that the other SSRI's have. That way, it does't look as "blurred" with the other non-SSRi options.
(??)Mitch
Posted by Darwin on October 21, 2001, at 17:21:45
In reply to star-D and citalopram?, posted by JohnX on October 21, 2001, at 16:21:58
I think this question was answered in part in the "Treatment Resistant Depression" presentation. Two of the reasons given:
1. Citalopram will soon come of patent
protection for lower cost.2. Citalopram has an advantage over fluoxetine
in that its shorter half-life allows for
faster switching to new medications.Darwin
> Why start with cytalopram in this
> star-D program? I hope this
> is this because of its lack of
> interactions with other meds, and
> not Forest Labs marketing/sales team
> which throws extravagant parties for
> psychiatrists (according both to my pdoc
> and a close pharmacist friend).
>
> -john
This is the end of the thread.
Psycho-Babble Medication | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
bob@dr-bob.org
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.